BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 15852400)

  • 1. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications.
    Bubber P; Haroutunian V; Fisch G; Blass JP; Gibson GE
    Ann Neurol; 2005 May; 57(5):695-703. PubMed ID: 15852400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease.
    Mastrogiacoma F; Lindsay JG; Bettendorff L; Rice J; Kish SJ
    Ann Neurol; 1996 May; 39(5):592-8. PubMed ID: 8619544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricarboxylic acid cycle enzymes following thiamine deficiency.
    Bubber P; Ke ZJ; Gibson GE
    Neurochem Int; 2004 Dec; 45(7):1021-8. PubMed ID: 15337301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
    Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.
    Gibson GE; Haroutunian V; Zhang H; Park LC; Shi Q; Lesser M; Mohs RC; Sheu RK; Blass JP
    Ann Neurol; 2000 Sep; 48(3):297-303. PubMed ID: 10976635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical assays for mitochondrial activity: assays of TCA cycle enzymes and PDHc.
    Reisch AS; Elpeleg O
    Methods Cell Biol; 2007; 80():199-222. PubMed ID: 17445696
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral citric acid cycle enzymes in methionine sulfoximine toxicity.
    Ratnakumari L; Subbalakshmi GY; Murthy CR
    J Neurosci Res; 1985; 14(4):449-59. PubMed ID: 4078940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease.
    Sheu KF; Cooper AJ; Koike K; Koike M; Lindsay JG; Blass JP
    Ann Neurol; 1994 Mar; 35(3):312-8. PubMed ID: 8122883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain.
    Sheu KF; Kim YT; Blass JP; Weksler ME
    Ann Neurol; 1985 May; 17(5):444-9. PubMed ID: 4004169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease.
    Prohovnik I; Perl DP; Davis KL; Libow L; Lesser G; Haroutunian V
    Neurology; 2006 Jan; 66(1):49-55. PubMed ID: 16401845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities in the tricarboxylic Acid cycle in Huntington disease and in a Huntington disease mouse model.
    Naseri NN; Xu H; Bonica J; Vonsattel JP; Cortes EP; Park LC; Arjomand J; Gibson GE
    J Neuropathol Exp Neurol; 2015 Jun; 74(6):527-37. PubMed ID: 25978848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain.
    Sorbi S; Bird ED; Blass JP
    Ann Neurol; 1983 Jan; 13(1):72-8. PubMed ID: 6219611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial aging and dysfunction in Alzheimer's disease.
    Sullivan PG; Brown MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):407-10. PubMed ID: 15795049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levo carnitine and alpha lipoic acid in ameliorating the decline in mitochondrial enzymes during aging.
    Savitha S; Sivarajan K; Haripriya D; Kokilavani V; Panneerselvam C
    Clin Nutr; 2005 Oct; 24(5):794-800. PubMed ID: 15919137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathologic correlates of activities of daily living in Alzheimer disease.
    Marshall GA; Fairbanks LA; Tekin S; Vinters HV; Cummings JL
    Alzheimer Dis Assoc Disord; 2006; 20(1):56-9. PubMed ID: 16493237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study.
    Michel TM; Gsell W; Käsbauer L; Tatschner T; Sheldrick AJ; Neuner I; Schneider F; Grünblatt E; Riederer P
    J Alzheimers Dis; 2010; 19(4):1295-301. PubMed ID: 20061610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients.
    Bubber P; Hartounian V; Gibson GE; Blass JP
    Eur Neuropsychopharmacol; 2011 Mar; 21(3):254-60. PubMed ID: 21123035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
    Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
    Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of mitochondrial enzymes in Alzheimer disease.
    Gibson GE; Sheu KF; Blass JP
    J Neural Transm (Vienna); 1998; 105(8-9):855-70. PubMed ID: 9869323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.